CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational parainfluenza ...

Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

It’s not like no one has tried. In the late ‘90s and early aughts, a now-defunct company, ViroPharma, developed an antiviral ...

These diseases are not only harmful and highly contagious but can also render entire farms or regions vulnerable to outbreaks. Importantly, the existence of viruses such as Bovine Parainfluenza Virus ...

Early results from 63 of the infants enrolled in the trial found the vaccine to be safe, tolerated and able to cut the chance ...

Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection Dec ... H5N1 influenza virus currently circulating ... New Model for Replication of BKPyV Virus, a Major ...

Single Mutation in H5N1 Influenza Surface Protein Could Enable Easier Human Infection Dec ... H5N1 influenza virus currently circulating ... New Model for Replication of BKPyV Virus, a Major ...

The human rights group concludes that Israel’s war on Gaza meets the legal threshold for genocide in a damning report. Facing threats of a crackdown at the US border, migrants consider whether ...

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that Dr. Jenny Fox of Children's ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.DyCR3BqR.js ...